Aditxt Inc (ADTX)
2.08
-0.01
(-0.48%)
USD |
NASDAQ |
May 21, 16:00
2.11
+0.03
(+1.44%)
After-Hours: 20:00
Aditxt Enterprise Value: 19.53M for May 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 21, 2024 | 19.53M |
| May 20, 2024 | 19.55M |
| May 17, 2024 | 19.42M |
| May 16, 2024 | 19.42M |
| May 15, 2024 | 19.48M |
| May 14, 2024 | 19.73M |
| May 13, 2024 | 19.50M |
| May 10, 2024 | 19.52M |
| May 09, 2024 | 19.52M |
| May 08, 2024 | 19.57M |
| May 07, 2024 | 19.47M |
| May 06, 2024 | 19.67M |
| May 03, 2024 | 19.90M |
| May 02, 2024 | 20.18M |
| May 01, 2024 | 20.08M |
| April 30, 2024 | 20.08M |
| April 29, 2024 | 20.08M |
| April 26, 2024 | 20.05M |
| April 25, 2024 | 20.28M |
| April 24, 2024 | 20.02M |
| April 23, 2024 | 19.85M |
| April 22, 2024 | 19.77M |
| April 19, 2024 | 19.98M |
| April 18, 2024 | 20.08M |
| April 17, 2024 | 19.98M |
| Date | Value |
|---|---|
| April 16, 2024 | 20.12M |
| April 15, 2024 | 20.52M |
| April 12, 2024 | 21.08M |
| April 11, 2024 | 21.32M |
| April 10, 2024 | 21.26M |
| April 09, 2024 | 21.56M |
| April 08, 2024 | 21.25M |
| April 05, 2024 | 21.25M |
| April 04, 2024 | 21.46M |
| April 03, 2024 | 21.22M |
| April 02, 2024 | 21.68M |
| April 01, 2024 | 21.36M |
| March 28, 2024 | 21.73M |
| March 27, 2024 | 21.13M |
| March 26, 2024 | 21.24M |
| March 25, 2024 | 21.36M |
| March 22, 2024 | 21.30M |
| March 21, 2024 | 21.22M |
| March 20, 2024 | 21.41M |
| March 19, 2024 | 21.15M |
| March 18, 2024 | 21.26M |
| March 15, 2024 | 21.68M |
| March 14, 2024 | 22.28M |
| March 13, 2024 | 22.35M |
| March 12, 2024 | 22.21M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-4.536M
Minimum
Dec 28 2022
63.73M
Maximum
Feb 11 2021
15.85M
Average
11.86M
Median
Feb 08 2022
Enterprise Value Benchmarks
| Evofem Biosciences Inc | 43.22M |
| Perspective Therapeutics Inc | 811.05M |
| Electromed Inc | 135.78M |
| Xtant Medical Holdings Inc | 120.67M |
| Asensus Surgical Inc | 59.55M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -10.97M |
| Revenue (Quarterly) | 0.0813M |
| Total Expenses (Quarterly) | 8.032M |
| EPS Diluted (Quarterly) | -8.432 |
| Gross Profit Margin (Quarterly) | -251.6% |
| Profit Margin (Quarterly) | -13.49K% |
| Earnings Yield | -7.04K% |
| Normalized Earnings Yield | -7038.55 |